Stock listing
LENZ Stock Price, News, Filings & Events — Lenz Therapeutics, Inc.
Selected listing: LENZ · NASDAQ · USD · US
This page tracks Lenz Therapeutics, Inc.'s LENZ:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LENZ:NASDAQ. LENZ:NASDAQ is the stock-level entry point for investors researching Lenz Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lenz Therapeutics, Inc. (Ticker: LENZ) is a publicly traded company based in the United States, with a market capitalization of approximately $171.8 million. The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its public company page.
- Ticker
- LENZ:NASDAQ
- Asset type
- Stock
- Market cap
- $160.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Lenz Therapeutics, Inc. LENZ:NASDAQ stock context
This page tracks Lenz Therapeutics, Inc.'s LENZ:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LENZ:NASDAQ. LENZ:NASDAQ is the stock-level entry point for investors researching Lenz Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lenz Therapeutics, Inc. (Ticker: LENZ) is a publicly traded company based in the United States, with a market capitalization of approximately $171.8 million. The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its public company page.
Latest news from Lenz Therapeutics, Inc.
LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
August 4, 2026
LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presby...
July 6, 2026
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Z...
June 24, 2026
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
June 7, 2026
LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 11, 2026
Lenz Therapeutics, Inc. earnings calls
LENZ Therapeutics, Inc. (LENZ) Q2 2026 Earnings Call
August 11, 2026 · Replay with transcript and chapters
LENZ Therapeutics, Inc. (LENZ) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
LENZ Therapeutics, Inc. (LENZ) Q4 2025 Earnings Call
March 24, 2026 · Replay with transcript and chapters
LENZ Therapeutics, Inc. (LENZ) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call
March 19, 2025 · Replay with transcript and chapters
Research Lenz Therapeutics, Inc.
Lenz Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for LENZ:NASDAQ.
Lenz Therapeutics, Inc. company profile
View the public company page for Lenz Therapeutics, Inc. on 6ix.
Lenz Therapeutics, Inc. news
Read company news and market updates connected to Lenz Therapeutics, Inc..
Lenz Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Lenz Therapeutics, Inc..